@germ_nations ☐ UK 2003 - 2018 study: ☐ Women more than twice as likely as men to be diagnosed with anxiety & prescribed meds incl. antidepressants to relieve symptoms ☐ Study: https://t.co/fJT1QIzdU5 ☐ Summary: https://t.co/QmMDmJYcf6
@DrGrumpy @Altostrata @benzosarebad There’s several articles about it https://t.co/4bDNB2G7iu
@FearTheOni @BastardGrimm @benshapiro I'd normally say Google it but I'll be a gentleman - 1st thing that popped up https://t.co/jEvkIEPJYa
RT @joannamoncrieff: This study shows increased initiation of antidepressants for anxiety mainly in young people - a worrying trend
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @BNSSG_ICB: Congratulations to Dr Charlotte Archer for one of the most popular research papers of 2022 in the BJGP - another example of…
RT @BNSSG_ICB: Congratulations to Dr Charlotte Archer for one of the most popular research papers of 2022 in the BJGP - another example of…
RT @ArcherCS_: Delighted that our paper is in @BJGPjournal’s Top 10 most read papers for 2022 🎉
Congratulations to Dr Charlotte Archer for one of the most popular research papers of 2022 in the BJGP - another example of research supported by the Integrated Care Board. For more info about the research we support, see https://t.co/6Vmdf4DYkU @ArcherCS_
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @BJGPjournal: No. 7 #BJGPTop10 https://t.co/LENwT2wbbg
RT @ArcherCS_: Delighted that our paper is in @BJGPjournal’s Top 10 most read papers for 2022 🎉
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @recover2renew: Hmm.... !!
RT @recover2renew: ....and this research was before Covid!!
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @ArcherCS_: Delighted that our paper is in @BJGPjournal’s Top 10 most read papers for 2022 🎉
RT @ArcherCS_: Delighted that our paper is in @BJGPjournal’s Top 10 most read papers for 2022 🎉
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
Delighted that our paper is in @BJGPjournal’s Top 10 most read papers for 2022 🎉
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
RT @capcbristol: Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrK…
Great to see another @capcbristol paper in @BJGPjournal's top 10 for 2022! Congratulations to @ArcherCS_ & colleagues @DrKMTurner @Becky_mars_ & @sjmacneill David Kessler & Nicola Wiles.🥳👏 #BJGPTop10 @NIHRSPCR @sapcacuk @Brms_Research
RT @BJGPjournal: No. 7 #BJGPTop10 https://t.co/LENwT2wbbg
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
....and this research was before Covid!!
Hmm.... !!
RT @BJGPjournal: No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing…
No. 7 #BJGPTop10 – Rises in anxiety prescribing: prescribing increases may reflect better detection, but some prescribing is not evidence based https://t.co/oRYPy5CTQJ #PrimaryCare @ArcherCS_ @capcbristol @Brms_Research @NIHRSPCR @DrKMTurner @Becky_mars_
RT @recover2renew: AND THIS WAS BEFORE COVID!! Rise in #prescribing for #anxiety in UK #primarycare between 2003 and 2018: a population-ba…
RT @recover2renew: AND THIS WAS BEFORE COVID!! Rise in #prescribing for #anxiety in UK #primarycare between 2003 and 2018: a population-ba…
AND THIS WAS BEFORE COVID!! Rise in #prescribing for #anxiety in UK #primarycare between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink https://t.co/WWZQUP7dUh
RT @BJGPjournal: Increases in anxiolytic prescribing have been substantial in young adults in recent years, including benzodiazepine prescr…
RT @BJGPjournal: Increases in anxiolytic prescribing have been substantial in young adults in recent years, including benzodiazepine prescr…
RT @BJGPjournal: Increases in anxiolytic prescribing have been substantial in young adults in recent years, including benzodiazepine prescr…
RT @BJGPjournal: Increases in anxiolytic prescribing have been substantial in young adults in recent years, including benzodiazepine prescr…
Rise in #prescribing for #anxiety in UK #PrimaryCare between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink ✅Contact @NELPCKS for help with accessing journal articles / books / evidence searches #GeneralPractice h
RT @BJGPjournal: Increases in anxiolytic prescribing have been substantial in young adults in recent years, including benzodiazepine prescr…
Increases in anxiolytic prescribing have been substantial in young adults in recent years, including benzodiazepine prescribing. This may reflect better detection of #anxiety, but some prescribing is not based on robust evidence @ArcherCS_ ☞ https://t.co/
Prescribing for anxiety has increased in those under age 35 https://t.co/OhcWGUG5I8 https://t.co/DnbLTZjncu https://t.co/DEPAC3Hlpi
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @FarmaMadridAP: (BJGP) Incrementó en la prescripción de ansiolíticos en UK de 2003 -2018, alto en < 25 años y de 25-39 años https://t.c…
RT @FarmaMadridAP: (BJGP) Incrementó en la prescripción de ansiolíticos en UK de 2003 -2018, alto en < 25 años y de 25-39 años https://t.c…
(BJGP) Incrementó en la prescripción de ansiolíticos en UK de 2003 -2018, alto en < 25 años y de 25-39 años https://t.co/Mim1rbM7vZ
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines, <25 and 25–34 year olds) https://t.co/JbdqYAK8AA Figure shows prevalence by age group of any anxiolytic prescrip
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescribing is not based on robust evidence https://t.co/JbdqYAK8AA @ArcherCS_ https://t.co/PFFrIDcGKv via sanoysalvoblog
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @ArcherCS_: I spoke with the editor of @BJGPjournal about the rise in prescribing of anxiolytic medications for anxiety. Full podcast in…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @ArcherCS_: I spoke with the editor of @BJGPjournal about the rise in prescribing of anxiolytic medications for anxiety. Full podcast in…
RT @ArcherCS_: I spoke with the editor of @BJGPjournal about the rise in prescribing of anxiolytic medications for anxiety. Full podcast in…
RT @ArcherCS_: I spoke with the editor of @BJGPjournal about the rise in prescribing of anxiolytic medications for anxiety. Full podcast in…
I spoke with the editor of @BJGPjournal about the rise in prescribing of anxiolytic medications for anxiety. Full podcast interview here: https://t.co/8dhveemRSY @capcbristol @NIHRSPCR
RT @capcbristol: New @BJGPJournal podcast: @ArcherCS_ talks about her recently published research, which found a substantial increase in pr…
New @BJGPJournal podcast: @ArcherCS_ talks about her recently published research, which found a substantial increase in prescribing of anxiety medications in young adults. @NIHRSPCR @sapcacuk @Brms_Research @BristolUni @DrKMTurner #GPnews #primarycare #m
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
RT @recover2renew: ?? 🤔🤔
RT @recover2renew: ?? 🤔🤔
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
RT @BJGPjournal: @ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines,…
?? 🤔🤔
RT @BJGPjournal: Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescri…
@ArcherCS_ Anxiolytic prescribing by age, 2003–2018, with increases particularly for younger adults (blue and black lines, <25 and 25–34 year olds) https://t.co/oRYPy5CTQJ Figure shows prevalence by age group of any anxiolytic prescription per 1000 per
Increases in anxiolytic prescribing, especially in young adults, may reflect better detection of anxiety, but some prescribing is not based on robust evidence https://t.co/oRYPy5CTQJ @ArcherCS_ https://t.co/IAIq5OodDN
RT @NeuroscienceNew: “Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clini…
“Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink” by Charlotte Archer et al. British Journal of General Practice https://t.co/RYk5X2kl8q
RT @ArcherCS_: Our work published today by @BJGPjournal reports a rise in prescribing for anxiety @DrKMTurner @Becky_mars_ @sjmacneill Davi…
Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink https://t.co/scVY3Go246
RT @ArcherCS_: Our work published today by @BJGPjournal reports a rise in prescribing for anxiety @DrKMTurner @Becky_mars_ @sjmacneill Davi…
RT @joannamoncrieff: This study shows increased initiation of antidepressants for anxiety mainly in young people - a worrying trend
RT @joannamoncrieff: This study shows increased initiation of antidepressants for anxiety mainly in young people - a worrying trend
RT @joannamoncrieff: This study shows increased initiation of antidepressants for anxiety mainly in young people - a worrying trend
This study shows increased initiation of antidepressants for anxiety mainly in young people - a worrying trend